This article investigates the impact of the platelet-albumin-bilirubin (PALBI) score on the "textbook outcome" (TO) in patients with hepatocellular carcinoma (HCC) after liver resection, aiming to assess the value of preoperative PALBI score in predicting postoperative ideal clinical outcomes. TO is defined as a comprehensive indicator reflecting the absence of severe complications, perioperative mortality, prolonged hospital stay, re-admission within 30 days, and achievement of R0 resection, which can fully reflect the quality of surgery and perioperative management. The study, through a retrospective analysis of HCC patient data from West China Hospital of Sichuan University and Ziyang Central Hospital, found a significant correlation between higher PALBI scores and higher TO achievement rates, indicating that this score can serve as an important tool for preoperative assessment of patient surgical tolerance and prognosis. The innovation lies in the first systematic application of the PALBI score to TO prediction, providing a simple, objective, and clinically practical risk stratification method that helps optimize preoperative patient management and surgical decision-making. In addition, the study further verifies the applicability of TO as a comprehensive quality evaluation indicator in liver resection, supporting its use for comparing surgical quality between different medical institutions. The results also show that patients achieving TO have better recurrence-free survival (RFS) and overall survival (OS), consistent with previous studies on the impact of complications on long-term prognosis.
This study explores the impact of preoperative platelet-albumin-bilirubin (PALBI) score on the "textbook outcome" (TO) in patients with hepatocellular carcinoma (HCC) after liver resection, which has important clinical significance. TO comprehensively evaluates multiple perioperative quality indicators, including the absence of severe complications, perioperative mortality, prolonged hospital stay, re-admission within 30 days, and R0 resection, which can more fully reflect the quality of surgery and patient prognosis than a single indicator. The study shows that patients achieving TO have significantly better recurrence-free survival (RFS) and overall survival (OS) than those who do not, suggesting that achieving TO is closely related to improved long-term survival. In addition, as a comprehensive indicator reflecting liver reserve function and systemic inflammation, the PALBI score helps identify high-risk patients preoperatively, optimize surgical decision-making and perioperative management. This study provides a simple and effective evaluation tool for predicting outcomes after HCC liver resection and supports the use of TO as a standardized indicator for evaluating surgical quality, promoting the comparability and quality improvement of surgical outcomes between different medical institutions.